Loading
A medical oncologist who co-leads Tata Memorial's lung cancer trials and built India's geriatric oncology programme.
Vanita Noronha is Professor of Medical Oncology at Tata Memorial Hospital, part of the Tata Memorial Centre in Mumbai, working in geriatric oncology and lung cancer. She co-leads the hospital's lung cancer trials and co-led the trial of gefitinib with or without pemetrexed and carboplatin chemotherapy in EGFR-mutant lung cancer. She also built India's geriatric oncology programme, establishing a geriatric oncology clinic and research programme based on geriatric assessment. Her interests are lung cancer, geriatric oncology, head and neck cancer and clinical trials.
| Title | Journal | Year |
|---|---|---|
| Gefitinib versus gefitinib plus pemetrexed and carboplatin chemotherapy in EGFR-mutated lung cancer | Journal of Clinical Oncology | 2020 |
| Low-dose immunotherapy in head and neck cancer: a randomised study (Tata Memorial) | Journal of Clinical Oncology | 2023 |
Shares Low-dose immunotherapy in head and neck cancer: a randomised study (Tata Memorial), Gefitinib vs gefitinib plus pemetrexed-carboplatin in EGFR-mutant lung cancer (Tata Memorial), Oral metronomic chemotherapy vs intravenous cisplatin (Tata Memorial), Low-dose nivolumab plus metronomic chemotherapy (Tata Memorial).
Shares Low-dose immunotherapy in head and neck cancer: a randomised study (Tata Memorial), Oral metronomic chemotherapy vs intravenous cisplatin (Tata Memorial), Low-dose nivolumab plus metronomic chemotherapy (Tata Memorial), Tata Memorial Centre.
Shares Tata Memorial Centre, Head and neck squamous cell carcinoma.
Shares Oral metronomic chemotherapy vs intravenous cisplatin (Tata Memorial), Tata Memorial Centre, Head and neck squamous cell carcinoma.
Shares Tata Memorial Centre, Head and neck squamous cell carcinoma.
Shares Tata Memorial Centre, Head and neck squamous cell carcinoma.
Shares Tata Memorial Centre, Head and neck squamous cell carcinoma.